Yi-min E. Liu

250 Wuxing Street
Taipei, TNQ 11031, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different models.

A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different models.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 30, 2025

Clinical impact of pharmacogenetic risk variants in a large chinese cohort.

Clinical impact of pharmacogenetic risk variants in a large chinese cohort.

Journal: Nature communications

Published: October 25, 2024

The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.

The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.

Journal: Nature

Published: October 14, 2024

Population-specific polygenic risk scores for people of Han Chinese ancestry.

Population-specific polygenic risk scores for people of Han Chinese ancestry.

Journal: Nature

Published: October 14, 2024

Zinc Finger Protein 639 Expression Is a Novel Prognostic Determinant in Breast Cancer.

Zinc Finger Protein 639 Expression Is a Novel Prognostic Determinant in Breast Cancer.

Journal: Journal of breast cancer

Published: September 24, 2024

An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 - present).

An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 - present).

Journal: Expert opinion on therapeutic patents

Published: May 30, 2023

Correction to "N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling".

Correction to "N-Sulfonyl-aminobiaryls as Antitubulin Agents and Inhibitors of Signal Transducers and Activators of Transcription 3 (STAT3) Signaling".

Journal: Journal of medicinal chemistry

Published: April 20, 2023

2,6-Difluorobenzamide derivatives as store-operated calcium channel (SOC) inhibitors.

2,6-Difluorobenzamide derivatives as store-operated calcium channel (SOC) inhibitors.

Journal: European journal of medicinal chemistry

Published: March 29, 2022

Downregulation of AlphaB-crystallin in Retinal Pigment Epithelial Cells Exposed to Diabetes-related Stimuli In Vivo and In Vitro.

Downregulation of AlphaB-crystallin in Retinal Pigment Epithelial Cells Exposed to Diabetes-related Stimuli In Vivo and In Vitro.

Journal: In vivo (Athens, Greece)

Published: August 29, 2021

Erratum: TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum.

Erratum: TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis: Erratum.

Journal: Theranostics

Published: January 27, 2021

Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo.

Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo.

Journal: European journal of medicinal chemistry

Published: November 13, 2020

Corrigendum to "1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma" [Eur. J. Med. Chem. 140 (2017) 84-91].

Corrigendum to "1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma" [Eur. J. Med. Chem. 140 (2017) 84-91].

Journal: European journal of medicinal chemistry

Published: July 21, 2020

Showing 1-12 of 41

Last Updated: 09/26/2026